INS and obesity due to melanocortin 4 receptor deficiency: On average, participants had been diagnosed with T2DM for 8 years, and 50% were on insulin medications, and the majority were in class 2 obesity (81%) and stage 2 hypertension per American College of Cardiology 2017 guidelines (81).